Parveen Shiraz
- Hematology top 10%
- Multiple Myeloma Research and Treatments 8
- Hematopoietic Stem Cell Transplantation 7
- Chronic Myeloid Leukemia Treatments 5
-
- CAR-T cell therapy research 8
-
- Acute Lymphoblastic Leukemia research 11
-
- Childhood Cancer Survivors' Quality of Life 4
-
- Lymphoma Diagnosis and Treatment 5
-
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Lori MufflyAngela M. CapraCharles P. QuesenberryRegan FultonLaurel A. HabelLouis FehrenbacherKimberly J. PayneVaibhav Agrawal
- Cited by
- HematologyOncologyCancer Research
- Partner nations
- United StatesCanada
In The Last Decade
Parveen Shiraz
29 papers receiving 324 citations
Peers
Comparison fields: 5 of 40
- Hematology 119
- Oncology 171
- Cancer Research 66
- Public Health, Environmental and Occupational Health 122
- Pediatrics, Perinatology and Child Health 61
Countries citing papers authored by Parveen Shiraz
This map shows the geographic impact of Parveen Shiraz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parveen Shiraz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parveen Shiraz more than expected).
Fields of papers citing papers by Parveen Shiraz
This network shows the impact of papers produced by Parveen Shiraz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parveen Shiraz. The network helps show where Parveen Shiraz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Parveen Shiraz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 21 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 7 | |
| 16 | 2020 | 0 | |
| 17 | 2020 | 10 | |
| 18 | 2018 | 21 | |
| 19 | 2015 | 12 | |
| 20 | 2014 | 70 |
About Parveen Shiraz
Parveen Shiraz is a scholar working on Hematology, Oncology and Genetics, having authored 35 papers that have together received 330 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (11 papers), CAR-T cell therapy research (8 papers), Multiple Myeloma Research and Treatments (8 papers), Hematopoietic Stem Cell Transplantation (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). The work is most often cited by research in Hematology (119 citations), Oncology (171 citations) and Cancer Research (66 citations). Parveen Shiraz has collaborated with scholars based in United States and Canada. Frequent co-authors include Lori Muffly, Angela M. Capra, Charles P. Quesenberry, Regan Fulton, Laurel A. Habel, Louis Fehrenbacher, Kimberly J. Payne, Vaibhav Agrawal, Wendy Stock and Theresa H.M. Keegan. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.